+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Healthcare Predictive Analytics Market By Application, By Component: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994175
UP TO OFF until Oct 24th 2024
The global healthcare predictive analytics market was valued at $14.6 billion in 2023, and is projected to reach $128.2 billion by 2033, growing at a CAGR of 24.3% from 2024 to 2033.

Predictive analytics is the process of using data to forecast future outcomes. The process uses data analysis, machine learning, artificial intelligence, and statistical models to find patterns that might predict future behavior. Healthcare practitioners can use predictive analytics to identify possibilities to make more effective and efficient clinical and operational decisions, forecast trends, and even control the spread of illnesses by analyzing historical and current healthcare data.

The growth of the healthcare predictive analytics market is driven by numerous factors. One of the primary drivers is rise in the adoption of electronic health records (EHRs) and digital healthcare systems. These systems generate vast amounts of data, ranging from patient demographics to clinical histories, thereby driving the healthcare predictive analytics market growth. In addition, increase in demand for personalized medicine and value-based care models is propelling the demand of predictive analytics solutions. These tools empower clinicians to customize treatments based on individual patient characteristics, leading to more effective and efficient care delivery.

However, data privacy and security concerns hinder the growth of the market. Healthcare data is highly sensitive and subject to stringent regulatory requirements such as HIPAA in the U.S. Ensuring compliance while harnessing the full potential of predictive analytics poses a considerable hurdle for healthcare organizations. Contrarily, technological advancements in the healthcare predictive analytics sector offer lucrative opportunities to manufacturers in the sector to innovate. For instance, in September 2021, Healthcare analytics company Trilliant Health developed a new predictive analytics tool that enables strategy teams to see a 10-year view of the healthcare market with insights all the way down to the local market level.

Segmentation Overview

The healthcare predictive analytics market is segmented into application, component, end user, and region. Depending on the application, the market is categorized into clinical analytics, financial analytics, operational analytics, and others. Depending on the component, it is bifurcated into hardware and software. By end user, the market is divided into payers, providers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Scenario

The major players operating in the healthcare predictive analytics industry include IBM, Cerner Corp., Verisk Analytics, Inc., McKesson Corp., SAS Institute, Oracle, Allscripts, Cotiviti, Inc., Citius Tech Inc, and Optum, Inc. Other players in healthcare predictive analytics market includes ExlServices Holdings, Evidation Health, and MedeAnalytics, Inc. These players have maintained and are sustaining their position in the market by adopted different strategies, including product development & innovation, mergers & acquisitions, diversification, marketing & advertising, and mergers & acquisitions.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Application

  • Clinical Analytics
  • Financial Analytics
  • Operational Analytics
  • Others

By Component

  • Hardware
  • Software

By End-User

  • Payers
  • Providers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • IBM
  • Optum, Inc.
  • Cotiviti, Inc.,
  • Cerner Corporation
  • Verisk Analytics, Inc.
  • McKesson Corporation.
  • SAS Institute Inc
  • Oracle Corp
  • Allscripts
  • Citius Tech Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY APPLICATION
4.1. Market Overview
4.1.1 Market Size and Forecast, By Application
4.2. Clinical Analytics
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Financial Analytics
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Operational Analytics
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Others
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY COMPONENT
5.1. Market Overview
5.1.1 Market Size and Forecast, By Component
5.2. Hardware
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Software
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY END-USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End-user
6.2. Payers
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Providers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Application
7.2.3. Market Size and Forecast, By Component
7.2.4. Market Size and Forecast, By End-user
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Healthcare Predictive Analytics Market
7.2.6.1. Market Size and Forecast, By Application
7.2.6.2. Market Size and Forecast, By Component
7.2.6.3. Market Size and Forecast, By End-user
7.2.7. Canada Healthcare Predictive Analytics Market
7.2.7.1. Market Size and Forecast, By Application
7.2.7.2. Market Size and Forecast, By Component
7.2.7.3. Market Size and Forecast, By End-user
7.2.8. Mexico Healthcare Predictive Analytics Market
7.2.8.1. Market Size and Forecast, By Application
7.2.8.2. Market Size and Forecast, By Component
7.2.8.3. Market Size and Forecast, By End-user
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Application
7.3.3. Market Size and Forecast, By Component
7.3.4. Market Size and Forecast, By End-user
7.3.5. Market Size and Forecast, By Country
7.3.6. France Healthcare Predictive Analytics Market
7.3.6.1. Market Size and Forecast, By Application
7.3.6.2. Market Size and Forecast, By Component
7.3.6.3. Market Size and Forecast, By End-user
7.3.7. Germany Healthcare Predictive Analytics Market
7.3.7.1. Market Size and Forecast, By Application
7.3.7.2. Market Size and Forecast, By Component
7.3.7.3. Market Size and Forecast, By End-user
7.3.8. Italy Healthcare Predictive Analytics Market
7.3.8.1. Market Size and Forecast, By Application
7.3.8.2. Market Size and Forecast, By Component
7.3.8.3. Market Size and Forecast, By End-user
7.3.9. Spain Healthcare Predictive Analytics Market
7.3.9.1. Market Size and Forecast, By Application
7.3.9.2. Market Size and Forecast, By Component
7.3.9.3. Market Size and Forecast, By End-user
7.3.10. UK Healthcare Predictive Analytics Market
7.3.10.1. Market Size and Forecast, By Application
7.3.10.2. Market Size and Forecast, By Component
7.3.10.3. Market Size and Forecast, By End-user
7.3.11. Rest Of Europe Healthcare Predictive Analytics Market
7.3.11.1. Market Size and Forecast, By Application
7.3.11.2. Market Size and Forecast, By Component
7.3.11.3. Market Size and Forecast, By End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Application
7.4.3. Market Size and Forecast, By Component
7.4.4. Market Size and Forecast, By End-user
7.4.5. Market Size and Forecast, By Country
7.4.6. China Healthcare Predictive Analytics Market
7.4.6.1. Market Size and Forecast, By Application
7.4.6.2. Market Size and Forecast, By Component
7.4.6.3. Market Size and Forecast, By End-user
7.4.7. Japan Healthcare Predictive Analytics Market
7.4.7.1. Market Size and Forecast, By Application
7.4.7.2. Market Size and Forecast, By Component
7.4.7.3. Market Size and Forecast, By End-user
7.4.8. India Healthcare Predictive Analytics Market
7.4.8.1. Market Size and Forecast, By Application
7.4.8.2. Market Size and Forecast, By Component
7.4.8.3. Market Size and Forecast, By End-user
7.4.9. South Korea Healthcare Predictive Analytics Market
7.4.9.1. Market Size and Forecast, By Application
7.4.9.2. Market Size and Forecast, By Component
7.4.9.3. Market Size and Forecast, By End-user
7.4.10. Australia Healthcare Predictive Analytics Market
7.4.10.1. Market Size and Forecast, By Application
7.4.10.2. Market Size and Forecast, By Component
7.4.10.3. Market Size and Forecast, By End-user
7.4.11. Rest of Asia-Pacific Healthcare Predictive Analytics Market
7.4.11.1. Market Size and Forecast, By Application
7.4.11.2. Market Size and Forecast, By Component
7.4.11.3. Market Size and Forecast, By End-user
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Application
7.5.3. Market Size and Forecast, By Component
7.5.4. Market Size and Forecast, By End-user
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Healthcare Predictive Analytics Market
7.5.6.1. Market Size and Forecast, By Application
7.5.6.2. Market Size and Forecast, By Component
7.5.6.3. Market Size and Forecast, By End-user
7.5.7. South Africa Healthcare Predictive Analytics Market
7.5.7.1. Market Size and Forecast, By Application
7.5.7.2. Market Size and Forecast, By Component
7.5.7.3. Market Size and Forecast, By End-user
7.5.8. Saudi Arabia Healthcare Predictive Analytics Market
7.5.8.1. Market Size and Forecast, By Application
7.5.8.2. Market Size and Forecast, By Component
7.5.8.3. Market Size and Forecast, By End-user
7.5.9. Rest of LAMEA Healthcare Predictive Analytics Market
7.5.9.1. Market Size and Forecast, By Application
7.5.9.2. Market Size and Forecast, By Component
7.5.9.3. Market Size and Forecast, By End-user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. IBM
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Optum, Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Cotiviti, Inc.,
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Cerner Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Verisk Analytics, Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. McKesson Corporation.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. SAS Institute Inc
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Oracle Corp
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Allscripts
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Citius Tech Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 2. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OPERATIONAL ANALYTICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 7. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR HARDWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 10. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR PAYERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR PROVIDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. HEALTHCARE PREDICTIVE ANALYTICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 18. U.S. HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. U.S. HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 20. U.S. HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 21. CANADA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. CANADA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 23. CANADA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. FRANCE HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 36. GERMANY HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 37. ITALY HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. ITALY HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 39. ITALY HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. SPAIN HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 43. UK HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. UK HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 45. UK HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 53. CHINA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. CHINA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 55. CHINA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 58. JAPAN HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 59. INDIA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. INDIA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 61. INDIA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. SOUTH KOREA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. AUSTRALIA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 67. AUSTRALIA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. SOUTH AFRICA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 83. SAUDI ARABIA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA HEALTHCARE PREDICTIVE ANALYTICS, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 87. IBM: KEY EXECUTIVES
TABLE 88. IBM: COMPANY SNAPSHOT
TABLE 89. IBM: OPERATING SEGMENTS
TABLE 90. IBM: PRODUCT PORTFOLIO
TABLE 91. IBM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. OPTUM, INC.: KEY EXECUTIVES
TABLE 93. OPTUM, INC.: COMPANY SNAPSHOT
TABLE 94. OPTUM, INC.: OPERATING SEGMENTS
TABLE 95. OPTUM, INC.: PRODUCT PORTFOLIO
TABLE 96. OPTUM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. COTIVITI, INC., : KEY EXECUTIVES
TABLE 98. COTIVITI, INC., : COMPANY SNAPSHOT
TABLE 99. COTIVITI, INC., : OPERATING SEGMENTS
TABLE 100. COTIVITI, INC., : PRODUCT PORTFOLIO
TABLE 101. COTIVITI, INC., : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. CERNER CORPORATION: KEY EXECUTIVES
TABLE 103. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 104. CERNER CORPORATION: OPERATING SEGMENTS
TABLE 105. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 106. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. VERISK ANALYTICS, INC.: KEY EXECUTIVES
TABLE 108. VERISK ANALYTICS, INC.: COMPANY SNAPSHOT
TABLE 109. VERISK ANALYTICS, INC.: OPERATING SEGMENTS
TABLE 110. VERISK ANALYTICS, INC.: PRODUCT PORTFOLIO
TABLE 111. VERISK ANALYTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. MCKESSON CORPORATION.: KEY EXECUTIVES
TABLE 113. MCKESSON CORPORATION.: COMPANY SNAPSHOT
TABLE 114. MCKESSON CORPORATION.: OPERATING SEGMENTS
TABLE 115. MCKESSON CORPORATION.: PRODUCT PORTFOLIO
TABLE 116. MCKESSON CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. SAS INSTITUTE INC: KEY EXECUTIVES
TABLE 118. SAS INSTITUTE INC: COMPANY SNAPSHOT
TABLE 119. SAS INSTITUTE INC: OPERATING SEGMENTS
TABLE 120. SAS INSTITUTE INC: PRODUCT PORTFOLIO
TABLE 121. SAS INSTITUTE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. ORACLE CORP: KEY EXECUTIVES
TABLE 123. ORACLE CORP: COMPANY SNAPSHOT
TABLE 124. ORACLE CORP: OPERATING SEGMENTS
TABLE 125. ORACLE CORP: PRODUCT PORTFOLIO
TABLE 126. ORACLE CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. ALLSCRIPTS: KEY EXECUTIVES
TABLE 128. ALLSCRIPTS: COMPANY SNAPSHOT
TABLE 129. ALLSCRIPTS: OPERATING SEGMENTS
TABLE 130. ALLSCRIPTS: PRODUCT PORTFOLIO
TABLE 131. ALLSCRIPTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. CITIUS TECH INC.: KEY EXECUTIVES
TABLE 133. CITIUS TECH INC.: COMPANY SNAPSHOT
TABLE 134. CITIUS TECH INC.: OPERATING SEGMENTS
TABLE 135. CITIUS TECH INC.: PRODUCT PORTFOLIO
TABLE 136. CITIUS TECH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SEGMENTATION
FIGURE 2. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET
FIGURE 3. SEGMENTATION HEALTHCARE PREDICTIVE ANALYTICS MARKET
FIGURE 4. TOP INVESTMENT POCKET IN HEALTHCARE PREDICTIVE ANALYTICS MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEALTHCARE PREDICTIVE ANALYTICS MARKET
FIGURE 11. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SEGMENTATION, BY APPLICATION
FIGURE 12. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OPERATIONAL ANALYTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SEGMENTATION, BY COMPONENT
FIGURE 17. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR HARDWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SEGMENTATION, BY END-USER
FIGURE 20. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR PAYERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR PROVIDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. HEALTHCARE PREDICTIVE ANALYTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 27. COMPETITIVE DASHBOARD
FIGURE 28. COMPETITIVE HEATMAP: HEALTHCARE PREDICTIVE ANALYTICS MARKET
FIGURE 29. TOP PLAYER POSITIONING, 2023
FIGURE 30. IBM: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. IBM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. IBM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. OPTUM, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. OPTUM, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. OPTUM, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. COTIVITI, INC., : NET SALES, 2021-2023 ($BILLION)
FIGURE 37. COTIVITI, INC., : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. COTIVITI, INC., : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. CERNER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. CERNER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. CERNER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. VERISK ANALYTICS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. VERISK ANALYTICS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. VERISK ANALYTICS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. MCKESSON CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. MCKESSON CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. MCKESSON CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. SAS INSTITUTE INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. SAS INSTITUTE INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. SAS INSTITUTE INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. ORACLE CORP: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. ORACLE CORP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. ORACLE CORP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. ALLSCRIPTS: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. ALLSCRIPTS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. ALLSCRIPTS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. CITIUS TECH INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 58. CITIUS TECH INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. CITIUS TECH INC.: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • IBM
  • Optum, Inc.
  • Cotiviti, Inc.,
  • Cerner Corporation
  • Verisk Analytics, Inc.
  • McKesson Corporation.
  • SAS Institute Inc
  • Oracle Corp
  • Allscripts
  • Citius Tech Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information